Verona integron-encoded metallo-beta-lactamase–producing carbapenem-resistant enterobacteriaceae in a neonatal and adult intensive care unit — Kentucky, 2015

Morbidity and Mortality Weekly Report

Volumn 65, Issue 7, 2016, Pages 190-

  Yaffee, Anna Q ^a,b   Roser, Lynn ^b   Daniels, Kimberly ^b   Humbaugh, Kraig ^b   Brawley, Robert ^b   Thoroughman, Douglas ^a,b   Flinchum, Andrea ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Kentucky Department for Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; BIOSYNTHESIS; CHILD; DRUG EFFECTS; ENTEROBACTERIACEAE; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; INFANT; INTEGRON; INTENSIVE CARE UNIT; KENTUCKY; MALE; MIDDLE AGED; NEWBORN; NEWBORN INTENSIVE CARE; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BETA-LACTAMASES; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTEGRONS; INTENSIVE CARE UNITS; INTENSIVE CARE UNITS, NEONATAL; KENTUCKY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84959463453     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6507a5     Document Type: Article

References (8)

1. CDC. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE)—November 2015 update CRE toolkit. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. http://www.cdc.gov/hai/organisms/cre/cre-toolkit
2. CDC. Carbapenem-resistant Enterobacteriaceae in healthcare settings. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. http://www.cdc.gov/HAI/organisms/cre/index.html
3. Oteo J, Hernández-Almaraz JL, Gil-Antón J, et al. Outbreak of VIM-1- carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit. Pediatr Infect Dis J 2010;29:1144–6. http://dx.doi.org/10.1097/ INF.0b013e3181efaa2d
4. Juhász E, Jánvári L, Tóth A, Damjanova I, Nobilis A, Kristóf K. Emergence of VIM-4- and SHV-12-producing Enterobacter cloacae in a neonatal intensive care unit. Int J Med Microbiol 2012;302:257–60. http://dx.doi. org/10.1016/j.ijmm.2012.05.003
5. Moland ES, Hong SG, Cleary T, Morris MI, Hanson ND, Thomson KSUS. Isolate of Klebsiella pneumoniae (KP) producing VIM metallobeta- lactamase (MBL) and SHV-5-like ESBL. In: proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA: September 27–30, 2006.
6. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099–106. http://dx.doi.org/10.1086/592412
7. Falcone M, Mezzatesta ML, Perilli M, et al. Infections with VIM-1 metallo-beta-lactamase-producing Enterobacter cloacae and their correlation with clinical outcome. J Clin Microbiol 2009;47:3514–9. http://dx.doi.org/10.1128/JCM.01193-09
8. Ruppé E, Armand-Lefèvre L, Estellat C, et al. High rate of actionquisi but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics. Clin Infect Dis 2015;61:593–600. http://dx.doi.org/10.1093/cid/civ333